GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alligator Bioscience AB (OSTO:ATORX) » Definitions » Other Financing

Alligator Bioscience AB (OSTO:ATORX) Other Financing : kr-24.14 Mil (TTM As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Alligator Bioscience AB Other Financing?

Alligator Bioscience AB's Other Financing for the three months ended in Mar. 2024 was kr0.00 Mil.

Alligator Bioscience AB's Other Financing for the trailing twelve months (TTM) ended in Mar. 2024 was kr-24.14 Mil.

Alligator Bioscience AB Other Financing Historical Data

The historical data trend for Alligator Bioscience AB's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alligator Bioscience AB Other Financing Chart

Alligator Bioscience AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - -33.90 -0.45 -24.14

Alligator Bioscience AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -22.78 -51.23 49.87 -

Alligator Bioscience AB Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-24.14 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alligator Bioscience AB Other Financing Related Terms

Thank you for viewing the detailed overview of Alligator Bioscience AB's Other Financing provided by GuruFocus.com. Please click on the following links to see related term pages.

Alligator Bioscience AB (OSTO:ATORX) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alligator Bioscience AB (OSTO:ATORX) » Definitions » Other Financing
Comparable Companies
OSTO:BIOWKS OSTO:ABLI OSTO:MAGLE OSTO:ACOU OSTO:CLBIO OSTO:KAN XSAT:HAMLET B OSTO:STABL OSTO:GUARD OSTO:SANION OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
7AL:Germany
Address
Scheelevagen 2, Medicon Village, Lund, SWE, 223 81
Website
http://www.alligatorbioscience.com
Alligator Bioscience AB is a research-based biotechnology company that develops immune activating antibody drugs for tumor-directed immunotherapy. It is engaged in the development of immunotherapies for the treatment of cancer Its products are ADC-1013, ATOR-1015, and ATOR-1016.

Alligator Bioscience AB (OSTO:ATORX) Headlines

No Headlines